Advances in contraception: IUDs from a managed care perspective

Journal of Women's Health

Volumn 17, Issue 6, 2008, Pages 987-992

  Doyle, John ^a   Stern, Lee ^a,e   Hagan, Michael ^b   Hao, Jiayi ^c   Gricar, Joseph ^d  

^a Analytica International   (United States)

^b Bayer HealthCare Pharmaceuticals Inc   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d Analytica International ^*

^e Global Health Outcomes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

AMENORRHEA; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; ECTOPIC PREGNANCY; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MANAGED CARE; MENSTRUAL IRREGULARITY; MOOD DISORDER; NAUSEA; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAFETY; SIDE EFFECT; UNITED STATES; UNPLANNED PREGNANCY; WEIGHT GAIN;

CONTRACEPTION; CONTRACEPTIVE AGENTS; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; HUMANS; INTRAUTERINE DEVICES; MANAGED CARE PROGRAMS; PHYSICIAN'S ROLE; PREGNANCY; PREGNANCY, UNPLANNED; UNITED STATES;

EID: 49149123178     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0814     Document Type: Review

References (47)

1. Fertility, family planning, and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. (PHS) 2006-1977, 2006. Report No.: Series 23, No. 25.
2. Green DC, Gazmararian JA, Mahoney LD, Davis NA. Unintended pregnancy in a commercially insured population. Matern Child Health J 2002;6:181-187.
3. Mosher WD, Martinez GM, Chandra A, Abma JC, Wilson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004;350:1-36.
4. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-96.
5. Klima CS. Unintended pregnancy. Consequences and solutions for a worldwide problem. J Nurse Midwifery 1998;43:483-491.
6. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-29, 46.
7. Lee PR, Stewart FH. Failing to prevent unintended pregnancy is costly. Am J Public Health 1995;85:479-480.
8. Trussell J, Koenig J, Stewart F, Darroch JE. Medical care cost savings from adolescent contraceptive use. Fam Plann Perspect 1997;29:248-255, 295.
9. Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:56-63.
10. Jones EF, Forrest JD. Contraceptive failure rates based on the 1988 NSFG. Fam Plann Perspect 1992;24:12-19.
11. Rolnick SJ, Jackson JM, O'Connor P, DeFor T. Impact of birthweight on healthcare charges within a managed care organization. Am J Manag Care 2000;6:1289-1296.
12. Long SH, Marquis MS, Harrison ER. The costs and financing of perinatal care in the United States. Am J Public Health 1994;84:1473-1478.
13. St John EB, Nelson KG, Cliver SP, Bishnoi RR, Goldenberg RL. Cost of neonatal care according to gestational age at birth and survival status. Am J Obstet Gynecol 2000;182(1 Pt 1):170-175.
14. Evolution and revolution: The past, present, and future of contraception. Contraception Report 2000;10:15-25.
15. Kaunitz AM. Beyond the pill: New data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol 2005;192:998-1004.
16. Davis AJ. Advances in contraception. Obstet Gynecol Clin North Am 2000;27:597-610.
17. Grossman D, Ellertson C, Abuabara K, Blanchard K, Rivas FT. Barriers to contraceptive use in product labeling and practice guidelines. Am J Public Health 2006;96:791-799.
18. Huber LR, Hogue CJ, Stein AD, et al. Contraceptive use and discontinuation: Findings from the contraceptive history, initiation, and choice study. Am J Obstet Gynecol 2006;194:1290-1295.
19. Serfaty D. Medical aspects of oral contraceptive discontinuation. Adv Contracept 1992;8(Suppl 1):21-33.
20. The need for and cost of mandating private insurance coverage of contraception, 1998. Available at www.guttmacher.org/pubs/journals/gr01045. html Accessed May 8, 2006.
21. Frost JJ. Public or private providers? U.S. women's use of reproductive health services. Fam Plann Perspect 2001;33:4-12.
22. Nelson A. Contraceptive update Y2K: Need for contraception and new contraceptive options. Clin Cornerstone 2000;3:48-62.
23. Sonfield A, Gold RB, Frost JJ, Darroch JE. U.S. insurance coverage of contraceptives and the impact of contraceptive coverage mandates, 2002. Perspect Sex Reprod Health 2004;36:72-79.
24. Insurance Coverage of Contraceptives, 2007. Available at www.guttmacher.org/statecenter/spibs/spib_ICC.pdf
25. Trussell J, Koenig J, Ellertson C, Stewart F. Preventing unintended pregnancy: The cost-effectiveness of three methods of emergency contraception. Am J Public Health 1997;87:932-937.
26. Trussell J, Leveque JA, Koenig JD, et al. The economic value of contraception: A comparison of 15 methods. Am J Public Health 1995;85:494-503.
27. Current trends IUD safety: Report of a nationwide physician survey. MMWR 1997;46:969-974.
28. Salem R. New attention to the IUD: Expanding women's contraceptive options to meet their needs. Population Reports. Baltimore: Johns Hopkins Bloomberg School of Public Health, The INFO Project, 2006. Report No.: Vol 7 Series B.
29. World Health Organization. Improving access to quality care in family planning: Medical criteria for contraceptive use. Geneva: WHO, 1996:132:1-186.
30. The intrauterine device, 2007. Available at www.acog.org/publications/ patient_education/bp014.cfm Accessed 2007.
31. Johnson BA. Insertion and removal of intrauterine devices. Am Fam Physician 2005;71:95-102.
32. Penney G, Brechin S, de Souza A, et al. FFPRHC guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004;30:29-41.
33. ParaGard® intrauterine copper contraceptive. Prescribing information available at www.paragard.com/custom_images/Prescribing-Info.pdf Accessed January 18.
34. Schering O. Data on file, March 2006.
35. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994;49:56-72.
36. Sivin I, el Mahgoub S, McCarthy T, et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNG 20) and the copper T 380Ag intrauterine devices: A five-year randomized study. Contraception 1990;42:361-378.
37. Backman T, Rauramo I, Huhtala S, Koskenvuo M. Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol 2004;190:50-54.
38. Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991;78:291-298.
39. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-721.
40. Washington AE, Katz P. Ectopic pregnancy in the United States: Economic consequences and payment source trends. Obstet Gynecol 1993;81:287-292.
41. Bouyer J, Rachou E, Germain E, et al. Risk factors for extrauterine pregnancy in women using an intrauterine device. Fertil Steril 2000;74:899-908.
42. Ory HW. Ectopic pregnancy and intrauterine contraceptive devices: New perspectives. The Women's Health Study. Obstet Gynecol 1981;57:137-144.
43. Hassan MA, Killick SR. Is previous aberrant reproductive outcome predictive of subsequently reduced fecundity? Hum Reprod 2005;20:657-664.
44. Chiou CF, Trussell J, Reyes E, et al. Economic analysis of contraceptives for women. Contraception 2003;68:3-10.
45. French R, Van Vliet H, Cowan F, et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004:CD001776.
46. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 2007;75(Suppl 6):S161-166.
47. Kelly A. A multicenter, open-label, uncontrolled trial with levonorgestrel-releasing intrauterine system (LNG-IUS) to evaluate the insertion and counseling procedures: A manuscript. Berlex Laboratories Archives, 2003.